Congcong Li

机构：Hebei Medical University, Fudan University, Ruijin Hospital, Shenyang Normal University, Second Hospital of Hebei Medical University, Ministry of Education, Pudong Medical Center, General Hospital of Shenyang Military Region, Shanghai University of Medicine and Health Sciences, Karamay Central Hospital, Huashan Hospital, Command Hospital, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0002-4459-5224

发表论文 124 篇 · 总被引 3398 次 · h-index 24

代表论文

• Derazantinib Inhibits the Planktonic Growth and Biofilm Formation of Staphylococcus aureus by Binding Membrane Phospholipids and Disrupting the Cell Membrane (2025 · ACS Infectious Diseases · 被引 4)
• Lung Volume Reduction Therapies in Patients with Emphysema: A Systematic Review and Network Meta-Analysis (2025 · COPD Journal of Chronic Obstructive Pulmonary Disease · 被引 3)
• Baseline type 2 biomarker levels and clinical remission predictors in children with asthma (2025 · Frontiers in Immunology · 被引 3)
• Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis (2025 · Antibiotics · 被引 3)
• Icariside II targets M2 macrophages by regulating the inflammasome and profibrotic signaling in chronic asthma (2026 · Phytomedicine · 被引 2)
• N -Acetylcysteine-Capped TLQP21-Containing Au Nanocages Alleviate Depression in Mice (2025 · ACS Nano · 被引 2)